These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29557250)

  • 1. Effect of Intranasal Insulin on Olfactory Recovery in Patients with Hyposmia: A Randomized Clinical Trial.
    Rezaeian A
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1134-1139. PubMed ID: 29557250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intranasal sodium citrate on olfaction in post-infectious loss: results from a prospective, placebo-controlled trial in 49 patients.
    Whitcroft KL; Ezzat M; Cuevas M; Andrews P; Hummel T
    Clin Otolaryngol; 2017 Jun; 42(3):557-563. PubMed ID: 27860366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal insulin influences the olfactory performance of patients with smell loss, dependent on the body mass index: A pilot study.
    Schöpf V; Kollndorfer K; Pollak M; Mueller CA; Freiherr J
    Rhinology; 2015 Dec; 53(4):371-8. PubMed ID: 26275583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study.
    Henkin RI; Schultz M; Minnick-Poppe L
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1064-70. PubMed ID: 23165381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Insulin for the Treatment of Persistent Post-COVID-19 Olfactory Dysfunction.
    Cherobin GB; Guimarães RES; de Paula Gomes MC; Vasconcelos LOG; de Abreu LAN
    Otolaryngol Head Neck Surg; 2023 Sep; 169(3):719-724. PubMed ID: 37078341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal insulin for COVID-19-related smell loss.
    Daniel D; Paula LN; Eduardo BM; Daniel GA; Andrea DE; Fernando LN; Armando MC
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):201-205. PubMed ID: 37608216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal insulin reduces olfactory sensitivity in normosmic humans.
    Brünner YF; Benedict C; Freiherr J
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1626-30. PubMed ID: 23928664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal vitamin A is beneficial in post-infectious olfactory loss.
    Hummel T; Whitcroft KL; Rueter G; Haehner A
    Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2819-2825. PubMed ID: 28434127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia.
    Blomqvist EH; Lundblad L; Bergstedt H; Stjärne P
    Acta Otolaryngol; 2003 Sep; 123(7):862-8. PubMed ID: 14575403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an absorbable gelatin dressing impregnated with triamcinolone within the olfactory cleft on polypoid rhinosinusitis smell disorders.
    Bardaranfar MH; Ranjbar Z; Dadgarnia MH; Atighechi S; Mirvakili A; Behniafard N; Sadeghi M; Abbaslu F; Baradaranfar A
    Am J Rhinol Allergy; 2014; 28(2):172-5. PubMed ID: 24717956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia.
    Whitcroft KL; Merkonidis C; Cuevas M; Haehner A; Philpott C; Hummel T
    Rhinology; 2016 Dec; 54(4):368-374. PubMed ID: 27316224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.
    Lee MR; Wehring HJ; McMahon RP; Linthicum J; Cascella N; Liu F; Bellack A; Buchanan RW; Strauss GP; Contoreggi C; Kelly DL
    Schizophr Res; 2013 Apr; 145(1-3):110-5. PubMed ID: 23415472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.
    McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Vaccarino A; Macqueen G; Lewis GF; Kennedy SH
    Bipolar Disord; 2012 Nov; 14(7):697-706. PubMed ID: 23107220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders.
    Philpott CM; Erskine SE; Clark A; Leeper A; Salam M; Sharma R; Murty GE; Hummel T
    Clin Otolaryngol; 2017 Dec; 42(6):1295-1302. PubMed ID: 28339165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of olfaction in patients with pemphigus vulgaris.
    Meric A; Dogan R; Veyseller B; Su O; Ozucer B; Tugrul S; Ozturan O
    Am J Rhinol Allergy; 2014; 28(2):e90-4. PubMed ID: 24717939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid imaging of olfaction by functional MRI (fMRI): identification of presence and type of hyposmia.
    Levy LM; Henkin RI; Lin CS; Finley A
    J Comput Assist Tomogr; 1999; 23(5):767-75. PubMed ID: 10524865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale.
    Galindo-Mendez B; Trevino JA; McGlinchey R; Fortier C; Lioutas V; Novak P; Mantzoros CS; Ngo L; Novak V
    Contemp Clin Trials; 2020 Feb; 89():105934. PubMed ID: 31923471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction.
    Lee JJ; Peterson AM; Kallogjeri D; Jiramongkolchai P; Kukuljan S; Schneider JS; Klatt-Cromwell CN; Drescher AJ; Brunworth JD; Piccirillo JF
    Am J Otolaryngol; 2022; 43(2):103299. PubMed ID: 34894449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.
    Cha DS; Best MW; Bowie CR; Gallaugher LA; Woldeyohannes HO; Soczynska JK; Lewis G; MacQueen G; Sahakian BJ; Kennedy SH; Lui JP; Mansur RB; McIntyre RS
    J Affect Disord; 2017 Mar; 210():57-65. PubMed ID: 28013123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients.
    Whitcroft KL; Gunder N; Cuevas M; Andrews P; Menzel S; Haehner A; Hummel T
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2891-2897. PubMed ID: 33471169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.